(E)-1-(1-Ethoxyethoxy)-3,7-dimethylocta-2,6-diene
Common Name: |
(E)-1-(1-Ethoxyethoxy)-3,7-dimethylocta-2,6-diene |
IUPAC Name: |
(2E)-1-(1-ethoxyethoxy)-3,7-dimethylocta-2,6-diene |
Molecular Formula: |
C14H26O2 |
SMILES: |
CCOC(C)OCC=C(C)CCC=C(C)C |
Inchi: |
1S/C14H26O2/c1-6-15-14(5)16-11-10-13(4)9-7-8-12(2)3/h8,10,14H,6-7,9,11H2,1-5H3/b13-10+ |
Inchi Key: |
XJMAAOIVFHDJAK-JLHYYAGUSA-N |
Cas No: |
38019-89-5 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
226.36 |
Mass (g/mol) |
226.193 |
Molar Refractivity |
70.63 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
8 |
Rings |
|
TPSA |
18.46 |
Hetero Atoms |
2 |
Heavy Atoms |
16 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
286.00 to 287.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.005 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.71 |
LogP |
4.078 |
iLOGP |
3.81 |
XLOGP3 |
4.18 |
WLOGP |
4.08 |
MLOGP |
3.17 |
ESOL Log S |
-3.35 |
ESOL Solubility (mg/ml) |
0.101 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-4.28 |
Ali Solubility (mg/ml) |
0.01 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-3.15 |
Silicos-IT Solubility (mg/ml) |
0.16 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.71 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.583 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.957 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |